3rd Quarter - Report

RICCHETTI INCORPORATED for ELI LILLY AND COMPANY

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

issues pertaining to the importation of prescription drugs issues relating to the approval of follow-on biologics issues relating to cancer research issues relating to mental health parity issues related to drug safety legislation issues related to disclosure of company gifts

LobbyistCovered position, as disclosed
JEFF RICCHETTI —
STEVE RICCHETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

issues related to proposed reform of the US patent system (Patent Reform Act S 1145, H.R. 1908)

LobbyistCovered position, as disclosed
JEFF RICCHETTI —
STEVE RICCHETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1908 (110th)

Medicare/Medicaid MMM

issues related to the pharmaceutical reimbursement in HR 6331 (Medicare Improvements for Patients and Providers Act) issues relating to comparative effectiveness research issues relating to the use of tamper resistant Rx pads issues relating to the registry of education grant funding issues relating to Medicaid rebates

LobbyistCovered position, as disclosed
JEFF RICCHETTI —
STEVE RICCHETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6331 (110th)

Advertising ADV

issues relating to direct-to-consumer advertising of prescription drugs

LobbyistCovered position, as disclosed
JEFF RICCHETTI —
STEVE RICCHETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.